Showing results (31-40 of 160) with videos related to
Sort By:
Pageof 16
BMC Health Services Research|March 28, 2003
Cost of managing complications resulting from type 2 diabetes mellitus in CanadaJudith A O'Brien, Amanda R Patrick, J Jaime CaroValue in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|September 16, 2004
Estimating survival for cost-effectiveness analyses: a case study in atherothrombosisJ Jaime Caro, Khajak J Ishak, Kristen Migliaccio-WalleInternational Journal of MS Care|June 14, 2019
Assessment of Patients with Neuromyelitis Optica Spectrum Disorder Using the EQ-5DMaureen A Mealy, Audra Boscoe, Jaime Caro, et al.Applied Health Economics and Health Policy|December 9, 2016
Amplifying Each Patient's Voice: A Systematic Review of Multi-criteria Decision Analyses Involving PatientsKevin Marsh, J Jaime Caro, Alaa Hamed, et al.Diabetes Care|March 5, 2002
Lifetime costs of complications resulting from type 2 diabetes in the U.SJ Jaime Caro, Alexandra J Ward, Judith A O'BrienBone|December 7, 2005
Assessment of compliance with osteoporosis treatment and its consequences in a managed care populationKrista F Huybrechts, Khajak J Ishak, J Jaime CaroThe Journal of Clinical Psychiatry|January 14, 2003
The risk of diabetes during olanzapine use compared with risperidone use: a retrospective database analysisJ Jaime Caro, Alexandra Ward, Carey Levinton, et al.Pharmacoeconomics|July 3, 2017
Validation of a DICE Simulation Against a Discrete Event Simulation Implemented Entirely in CodeJörgen Möller, Sarah Davis, Matt Stevenson, et al.Expert Review of Pharmacoeconomics & Outcomes Research|October 8, 2009
Economic assessments of low molecular weight heparin in venous thromboembolismAlexandra Ward, Denis Getsios, Judith O'Brien, et al.Pharmacoeconomics|October 21, 2005
Pharmacological management of overactive bladder : a systematic and critical review of published economic evaluationsDenis Getsios, Wissam El-Hadi, Ingrid Caro, et al.Pageof 16